Skip to main navigation
Skip to main content
Skip to Footer
Google Tag Manager
Singapore
Novartis Site Directory
Our Work
Clinical Trials
Therapeutic Areas
Healthcare Professionals
About Us
Our Mission and Vision
Our Culture and Values
Our Strategy
Our Leadership
Company History
Corporate Responsibility
Contact Us
Products
Product Portfolio
Product Listing
News
News Archive
Featured News
Media Releases
Stories
Global News
Careers
Careers Search
Working at Novartis
Awards & Recognition
Learning and Development
Search
News Archive
Advanced Search
Basic Search
From Date:
To Date:
Show:
All
Featured News
Media Releases
In the News
Stories
Filter By
2020
May
Media Release
/
May 14, 2020
Novartis Singapore returns Job Support Scheme payout worth SGD3.7 Million; aids community efforts against COVID-19
Read More
2019
October
Media Release
/
Oct 21, 2019
Healthcare Support Remains Strong For Singaporeans With Advanced Breast Cancer, But Patients Call For Greater Disease Education, Survey Finds
Read More
September
Media Release
/
Sep 18, 2019
Migraine is a billion-dollar headache for Singapore, nationwide study finds
Read More
June
Media Release
/
Jun 20, 2019
Health Sciences Authority approves Novartis Kisqali®, the first and only CDK4/6 inhibitor that significantly extends life in women with HR+/ HER2- advanced breast cancer
Read More
2018
November
Media Release
/
Nov 22, 2018
World’s first migraine-specific prevention treatment now available in Singapore as Health Sciences Authority approves Novartis Aimovig®
Read More
Media Release
/
Nov 08, 2018
New social experiment by Novartis encourages Singaporeans to #StartAskin’ to get clear about psoriasis
Read More
July
Media Release
/
Jul 16, 2018
Health Sciences Authority approves Novartis Kisqali® for the treatment of Stage IV metastatic breast cancer in postmenopausal women
Read More
Twitter
Tweet
Facebook
Share
Share
Twitter
Facebook
LinkedIn
Email
Jump to Comments
Print
Save
You are here
Home
›
News
